BRIEF-Cross Country Healthcare Q3 Adjusted EPS USD 0.12 Vs. IBES Estimate USD 0.1

Reuters
07 Nov 2024

Nov 06 (Reuters) - Cross Country Healthcare Q3 adjusted EBITDA USD 10.339 million vs. IBES estimate USD 11.5 million. * Q3 gross margin 20.4% * Q3 EPS USD 0.08 * Q3 net income USD 2.555 million * Q3 revenue USD 315.119 million vs. IBES estimate USD 310.2 million * Q3 adjusted EBITDA margin 3.3%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10